...
首页> 外文期刊>Cell death & disease. >uPAR and cathepsin B shRNA impedes TGF-β1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway
【24h】

uPAR and cathepsin B shRNA impedes TGF-β1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway

机译:uPAR和组织蛋白酶B shRNA以XIAP依赖性途径阻碍TGF-β1驱动的脑膜瘤细胞增殖和侵袭

获取原文
           

摘要

Overexpression of transforming growth factor β1 (TGF-β1) has been linked to immune suppression, tumor angiogenesis, tumor cell migration, tumor cell survival, and tumor cell invasion in many cancers. In the present study, we found abundant expression of TGF-β1 in the microenvironment of four different pathological types of meningioma tumors. TGF-β1 induced invasion in malignant meningioma cells with an associated upregulation of urokinase-type plasminogen activator (uPA), uPAR, cathepsin B, and MMP-9, and this increase in proliferation was coupled with the expression of anti-apoptotic and pro-survival signaling molecules. In addition to the intense immunoreactivity of meningioma tumors to X-linked inhibitor to apoptosis (XIAP), its knockdown abolished the TGF-β1-induced proliferation of these cells. The stimulation of XIAP expression and the activation of pSMAD-2 is mediated by phosphatidylinositol 3-kinase (PI3K)- and MEK-dependent pathways, and the addition of anti-TGF-β1 antibodies prevented their expression with a consequent decrease in invasion. Bicistronic shRNA constructs targeting uPAR and cathepsin B (pUC) quenched TGF-β1-driven invasion and survival of meningioma cells by downregulation of XIAP and pSMAD-2 expression. Animal models with intracranial tumors showed elevated levels of TGF-β1, XIAP and pSMAD-2, and pUC treatment prevented this increased expression. Thus, targeted silencing of TGF-β1-induced signaling by pUC in meningioma would provide new treatment approaches for management of meningioma.. ? 2012 Macmillan Publishers Limited
机译:在许多癌症中,过度表达转化生长因子β1(TGF-β1)与免疫抑制,肿瘤血管生成,肿瘤细胞迁移,肿瘤细胞存活和肿瘤细胞侵袭有关。在本研究中,我们发现TGF-β1在四种不同病理类型的脑膜瘤肿瘤的微环境中大量表达。 TGF-β1诱导了恶性脑膜瘤细胞的侵袭,并伴有尿激酶型纤溶酶原激活剂(uPA),uPAR,组织蛋白酶B和MMP-9的上调,这种增殖的增加与抗凋亡和促凋亡的表达有关。生存信号分子。除了脑膜瘤肿瘤对X连锁抑制剂对细胞凋亡(XIAP)的强烈免疫反应性外,其敲除还消除了TGF-β1诱导的这些细胞的增殖。 XIAP表达的刺激和pSMAD-2的激活是由磷脂酰肌醇3激酶(PI3K)和MEK依赖性途径介导的,加入抗TGF-β1抗体会阻止其表达,从而减少侵袭。靶向uPAR和组织蛋白酶B(pUC)的Bicistronic shRNA构建体通过下调XIAP和pSMAD-2表达来淬灭TGF-β1驱动的脑膜瘤细胞的侵袭和存活。颅内肿瘤动物模型显示TGF-β1,XIAP和pSMAD-2水平升高,而pUC治疗阻止了这种表达的增加。因此,在脑膜瘤中pUC对TGF-β1诱导的信号传导的靶向沉默将为脑膜瘤的治疗提供新的治疗方法。 2012 Macmillan Publishers Limited

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号